Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q4 2024 (December 31)5holders +1
1new positions
0sold out
1famous investor
$0.34avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($69K), Clear Street LLC ($19K) and Citadel Advisors ($17K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $733 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 13,911 shares bought, net +13,911 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Armistice Capital, LLC | — | No change | 204,082 | $69K |
| Clear Street LLC | — | Add +0.4% | 55,133 | $19K |
| Citadel Advisors | — | Add +28.2% | 50,245 | $17K |
| Oarsman Capital, Inc. | — | New | 2,448 | $733 |
| UBS Group AG | — | Add +42.4% | 665 | $199 |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.